April 20, 2024
Stocks & Bonds
[STOCK WATCH] Ilyang Pharmaceutical falls 2.06%,
[THE INVESTOR] As of Sept. 14 10:25 A.M., Ilyang Pharmaceutical declined 2.06%, compared with yesterday, to 33,350 won. It had declined 3.47% through the past month. Standard deviation, which indicates variableness, records 1.5% over the same period of time over one month.
Compared with its close competitors within the same industry, KOSPI, since the monthly volatility of Ilyang Pharmaceutical was at a low level, the earnings rate over one month was also relatively lower than that of its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -2.3%.
The return-on-risk is below the industrial mean, 1.2, and thus the industrial comparison performance was not so good.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
Compared with its close competitors within the same industry, KOSPI, since the monthly volatility of Ilyang Pharmaceutical was at a low level, the earnings rate over one month was also relatively lower than that of its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -2.3%.
The return-on-risk is below the industrial mean, 1.2, and thus the industrial comparison performance was not so good.
By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.
